digicomphoto/iStock via Getty Images
Haemonetics Corporation (NYSE:HAE) stock dropped about 12% after the blood supplies company missed Q3 revenue estimates, despite posting a 3.7% year-over-year increase.
Quarterly revenue came in at $348.5M, falling short of consensus estimates by $3.88M.
Hospital revenue surged 24% on a
